News from @MedSurgPI and @StarBioPharmaConsulting: How can early-stage biotechs access senior expertise without blowing the budget? In our latest white paper, we explore how fractional service providers (FSPs) are helping emerging drug developers streamline operations, reduce costs, and accelerate timelines—without sacrificing quality. From regulatory strategy to real-world evidence, discover how FSPs can drive smarter growth in medical affairs and clinical development.
#biotech #drugdevelopment #medicalaffairs #fractionalservices
Unlocking Efficiency and Expertise The Strategic Value of FSPs in Drug Dev and MA 06 12 2025 F